Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
British Journal of Haematology|October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximabColleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
The American Journal of Surgical Pathology|May 15, 2026
Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP StudyKatrin S Kurz, Sarah L Ondrejka, Brett Collinge, et al.
Leukemia & Lymphoma|January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysisZeina Al-Mansour, Hongli Li, James R Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
The New England Journal of Medicine|November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaPatrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood|September 6, 2013
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndromeEkaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, et al.
Pediatric Transplantation|May 29, 2024
The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescentsUpton D Allen, Arnaud G L'Huillier, Catherine M Bollard, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Blood|December 13, 2018
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphomaDavid Martín-Garcia, Alba Navarro, Rafael Valdés-Mas, et al.
Pageof 31